← Back to Search

Advanced Care Planning for Sarcoma

N/A

Waitlist Available

Led By Megan Shen

Research Sponsored by Fred Hutchinson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, up to 4 weeks

Awards & highlights

No Placebo-Only Group

Summary

This trial tests a checklist tool to assess future mobility needs for sarcoma patients. It may help improve quality of life by helping them plan for their future needs.

Who is the study for?

This trial is for English-speaking adults over 18 with sarcoma who've had limb surgery or are in active treatment for stage IV sarcoma. They must be able to consent and have computer access. Caregivers meeting the same criteria can also participate.

What is being tested?

The study evaluates a checklist tool designed to assess future mobility needs of sarcoma patients post-surgery or during stage IV treatment, aiming to improve their quality of life by aiding in planning for mobility challenges.

What are the potential side effects?

Since this trial involves assessments through questionnaires and interviews rather than medical treatments, there are no direct physical side effects associated with participating.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ from baseline to after completion of intervention (+ 1 week)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~from baseline to after completion of intervention (+ 1 week)

This trial's timeline: 3 weeks for screening, Varies for treatment, and from baseline to after completion of intervention (+ 1 week) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Acceptability of the intervention: Acceptability E-Scale

Acceptability: Satisfaction with the intervention

Feasibility, as measured by the number of subjects accrued to the study

+2 more

Secondary study objectives

Change in completion of advance directives

Change in discussion of advance directives

Change in functional status

+2 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Supportive Care (advanced care planning checklist)Experimental Treatment4 Interventions

FIELD TEST: Participants complete the Advance Care Planning (ACP) Mobility Checklist on study. Participants complete questionnaires at baseline and after completing the checklist intervention and undergo interview on study. Participants medical records are also reviewed.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Assessment

2007

N/A

~2190

Do I qualify?Apply below to find out